Free Trial

Vitalhub (TSE:VHI) Stock Price Down 0.7% - What's Next?

Vitalhub logo with Medical background

Key Points

  • Vitalhub Corp. shares dropped by 0.7% to C$11.01 during trading, with an 18% decline in trading volume compared to the average.
  • Analysts have set a consensus price target of C$14.08, with firms like TD Securities and National Bank Financial rating the stock as a "buy" or "strong buy."
  • Insider trading activity includes significant sales by directors, with one director reducing their position by 25% and another by 22.39%.
  • MarketBeat previews the top five stocks to own by October 1st.

Vitalhub Corp. (TSE:VHI - Get Free Report)'s share price dropped 0.7% during mid-day trading on Monday . The stock traded as low as C$10.99 and last traded at C$11.01. Approximately 124,253 shares changed hands during mid-day trading, a decline of 18% from the average daily volume of 150,968 shares. The stock had previously closed at C$11.09.

Analysts Set New Price Targets

Several research firms have recently commented on VHI. TD Securities boosted their price target on shares of Vitalhub from C$15.00 to C$16.00 and gave the company a "buy" rating in a report on Monday, August 11th. National Bank Financial upgraded shares of Vitalhub to a "strong-buy" rating in a report on Monday, June 9th. National Bankshares set a C$16.00 price target on shares of Vitalhub and gave the company an "outperform" rating in a report on Thursday, August 21st. Raymond James Financial boosted their price target on shares of Vitalhub from C$14.50 to C$15.00 and gave the company an "outperform" rating in a report on Tuesday, August 12th. Finally, Scotiabank boosted their price target on shares of Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a report on Friday, June 20th. One research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of C$14.08.

Read Our Latest Analysis on Vitalhub

Vitalhub Trading Down 0.7%

The company has a market cap of C$691.76 million, a PE ratio of 137.63, a P/E/G ratio of 1.18 and a beta of 0.93. The firm's 50-day simple moving average is C$12.67 and its two-hundred day simple moving average is C$11.07.

Insider Activity at Vitalhub

In other Vitalhub news, Director Steve Garrington sold 20,000 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the sale, the director owned 60,000 shares of the company's stock, valued at approximately C$774,000. The trade was a 25.00% decrease in their position. Also, Director Danny Matlow sold 150,000 shares of the company's stock in a transaction on Thursday, August 28th. The shares were sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the completion of the sale, the director directly owned 520,001 shares in the company, valued at C$6,630,012.75. This trade represents a 22.39% decrease in their ownership of the stock. 18.57% of the stock is currently owned by insiders.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vitalhub Right Now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.